Robert S. Wallis

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial

D. Zak, Garnet Navarro, A. Aderem, 2016, EBioMedicine.

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial

Garnet Navarro, D. Hokey, Rebecca L. Podyminogin, 2016, EBioMedicine.

Cardiac safety of extensively drug-resistant tuberculosis regimens including bedaquiline, delamanid and clofazimine

Robert S. Wallis, 2016, European Respiratory Journal.

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial

A. Diacon, M. Hoelscher, K. Reither, 2017, The Lancet. Infectious diseases.